Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1007 | Thyroid | ECE2022

Quality of life and symptomatology in patients with hypothyroidism post-graves’ disease

Pereira Miguel , Neves Celestino , Goncalves Juliana , Neves Joao Se rgio , Carvalho Davide

Introduction: Quality of life (QoL) and its related physical and psychological symptomatology is an important factor when we treat Graves’ disease.Objective: To analyze the QoL and physical and psychological symptomatology of patients with hypothyroidism after definitive treatment of Graves’ disease.Methods: We evaluated 16 patients with hypothyroidism that previously had Graves’ disease. These patients were submitte...

ea0084op-04-21 | Oral Session 4: Basic 1 | ETA2022

CRYO-electron microscopy structures of human thyroid peroxidase (TPO) in complex with tpo antibodies

Baker Stuart , Nunez Miguel Ricardo , Thomas Daniel , Powell Michael , Furmaniak Jadwiga , Rees Smith Bernard

Objectives: Thyroid peroxidase (TPO) is a key enzyme in the synthesis of thyroid hormones and is a target for autoimmune responses in autoimmune thyroid disease. TPO autoantibody (TPOAb) binding epitopes have been mapped on the peroxidase domain (POD) and the complement control protein like domain (CCP). This study aimed to solve the molecular structures of TPO bound to TPO antibodies.Methods: An extracellular domain (ECD) of human TPO (amino acids; aa 1...

ea0090p557 | Adrenal and Cardiovascular Endocrinology | ECE2023

Retrospective study of steroid weaning in tertiary adrenal insufficiency comparing prednisolone and hydrocortisone

Fahad Arshad Muhammad , Elder Charlotte , Newell-Price John , Ross Richard , Debono Miguel

Background: The hypothalamic-pituitary-adrenal (HPA) axis can be suppressed by long-term exogenous glucocorticoids, resulting in tertiary adrenal insufficiency (AI). International expert consensus suggests that during weaning, prednisolone be converted to hydrocortisone to allow HPA axis reactivation(1). There is, however, little evidence to support this practice.Aim: To compare HPA axis recovery during treatment with prednisolone and immediat...

ea0090p692 | Pituitary and Neuroendocrinology | ECE2023

Characterisation of the clinical and biologic behaviour of acromegaly caused by pluri-hormonal tumours in a cohort of 75 patients

Martins Ferreira Mafalda , Carreira Ana , Cardoso Luis , Oliveira Patricia , Melo Miguel , Paiva Isabel

Introduction: The clinical and biochemical spectrum of pituitary acromegaly is wide and variable. There are pure somatotroph tumors(ST), immunohistochemically positive only for GH, and pluri-hormonal(PL), also positive for other hormones, and they appear to have different presentations and responses to treatment.Aims: To compare the clinical presentation, imaging characteristics and response to treatment of acromegalic patients according to the pituitary...

ea0090p505 | Thyroid | ECE2023

Thyroid hormones resistance, lipid profile and insulin resistance in autoimmune thyroiditis

Neves Celestino , Sergio Neves Joao , Goncalves Juliana , Pereira Miguel , Carvalho Davide

Introduction: Anomalies of glucose metabolism and insulin resistance are common in patients with hypothyroidism. Some studies suggests that euthyroid autoimmune thyroiditis (AIT) may also be associated with changes of glucose metabolism and insulin resistance. The role of thyroid hormones resistance in this context is still uncertain.Aim: To evaluate the relationship between thyroid hormones resistance, insulin resistance and lipid profile in euthyroid p...

ea0090p267 | Late-Breaking | ECE2023

Surgical outcomes in acromegaly: The influence of sex and menopause

Carreira Ana , Martins Ferreira Mafalda , Cardoso Luis , Guelho Daniela , Gomes Leonor , Melo Miguel , Paiva Isabel

Introduction: Oestrogens and androgens modulate the effects of growth hormone (GH). Sex differences have been described in acromegaly, with conflicting results in different populations. Additionally, data on sex differences in tumour histopathology are scarce.Aims: To analyse the influence of sex and menopause status in tumour characteristics and surgical outcomes in patients with acromegaly.Materials and methods: Retrospective coh...

ea0090ep1139 | Late Breaking | ECE2023

Metachronous Double Pituitary Adenomas: Presentation of A Case and Literature Analysis

Ruiz-Gines Miguel-Angel , Ruiz-Gines Juan-Antonio , Torres-Mateos Sandra

Introduction: Prolactinoma is the most frequent secreting pituitary tumor. They are usually treated with dopamine agonists (DA) (bromocriptine and cabergoline), which are very effective in most cases. DA resistance consists of the impossibility of reaching normal prolactin levels and/or reduction of the adenoma by at least 50%.Case presentation: We present the case of a 57-year-old man affected by visual disturbances and hypopituitarism (2019). Pituitary...

ea0090ep1143 | Late Breaking | ECE2023

Esthesioneuroblastoma As a Cause of Panhypopituitarism: Literature Analysis and Description of An Rare Case

Ruiz-Gines Miguel-Angel , Ruiz-Gines Juan-Antonio , Torres-Mateos Sandra

Introduction: Esthesioneuroblastoma (ENB), also known as olfactory neuroblastoma, is a malignant neuroendocrine tumor of the nasal fossa that arises from neurosensory receptor cells of the olfactory epithelium. It represents 3% of all nasal tumors. It presents a slow and progressive evolution that primarily affects the upper nasal mucosa and cribriform plate, with subsequent extension to the entire cavity and paranasal sinuses and can invade the orbit and cranial base.<p c...

ea0063p126 | Diabetes, Obesity and Metabolism 1 | ECE2019

Microvascular and macrovascular complications in a cohort of patients with type 2 diabetes mellitus

Herranz-Antolin Sandra , Frutos Visitacion Alvarez-de , Torralba Miguel , Biedma-Mendez Andrea

Objective: To assess the prevalence of complications In a cohort of patients with type 2 diabetes mellitus (T2DM).Material and methods: Prospective cohort study. 465 patients with T2DM who were not followed-up at an endocrinology clinic were included. The follow-up was carried out during 26 weeks. The prevalence of complications was evaluated throughout the study. This study was approved by the Ethics and Clinical Research Committee of the University Hos...

ea0063p396 | Thyroid 1 | ECE2019

Is detection of braf mutation enough to decide prophylactic central neck dissection (CND)?

Paja Miguel , Exposito Amaia , Arrizabalaga Cristina , Martinez Adela L , Monzon Andoni , Oleaga Amelia

Introduction: Most recent ATA thyroid nodule/DTC guidelines recommend thyroidectomy without prophylactic CND for small (T1 or T2), non-invasive, clinically node-negative PTC (cN0). However, some studies have suggested an association between the BRAFV600E mutation and the risk of nodal disease. Moreover, BRAF V600E mutation have recently showed significant association with recurrence in solitary intrathyroidal PTC between 2 and 4 cm (pT2) making suitable a more aggressive treat...